Capillary Technologies India Share Price
515.05+0.00 (+2.38%)
-15.08% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
TCSNSE
INFYNSE
HCLTECHNSE
WIPRONSE
TECHMNSE
LTMNSE
PERSISTENTNSE
COFORGENSE
OFSSNSE
MPHASISNSE
CAPILLARYNSE
Capillary Technologies India Share Price
515.05+0.00 (+2.38%)
-15.08% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 34% | 42% | 23% |
| - | - | - | 270% |
| - | - | - | -15% |
| -81% | -61% | -5% | 7% |
Peer Comparison
Symbol
TCS
INFY
HCLTECH
WIPRO
TECHM
LTM
PERSISTENT
COFORGE
OFSS
MPHASIS
CAPILLARY
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 2,489 | ₹849020 Cr | 16.45 | 38.35 | 157.25 | ₹49210 Cr |
| 988.2 | ₹442577 Cr | 14.39 | 19.31 | 88.54 | ₹29440 Cr |
| 1,410 | ₹361352 Cr | 19.72 | 18.9 | 83.25 | ₹16642 Cr |
| 189 | ₹182660 Cr | 13.87 | 3.23 | 16.54 | ₹13197 Cr |
| 1,753.2 | ₹168889 Cr | 30.56 | 17.9 | 76.02 | ₹4811 Cr |
| 4,202.3 | ₹121481 Cr | 23.24 | 47.23 | 211.46 | ₹5018 Cr |
| 6,148 | ₹97142 Cr | 53.87 | 22.28 | 138.35 | ₹1865 Cr |
| 2,095 | ₹91065 Cr | 46.24 | 13.28 | 64.24 | ₹1556 Cr |
| 9,832.5 | ₹85842 Cr | 24.05 | 80.55 | 416.36 | ₹2639 Cr |
| 2,409 | ₹45479 Cr | 22.71 | 29.38 | 135.94 | ₹1863 Cr |
| 502.55 | ₹4016 Cr | 63.03 | 2.75 | 18.42 | ₹52 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| ₹271 Cr | ₹257 Cr | ₹191 Cr | ₹184 Cr | ₹179 Cr | ₹180 Cr | ₹152 Cr | ₹159 Cr |
| ₹6 Cr | ₹6 Cr | ₹7 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr | ₹3 Cr | ₹1 Cr |
| ₹277 Cr | ₹262 Cr | ₹198 Cr | ₹188 Cr | ₹182 Cr | ₹181 Cr | ₹155 Cr | ₹160 Cr |
| ₹256 Cr | ₹236 Cr | ₹179 Cr | ₹178 Cr | ₹180 Cr | ₹179 Cr | ₹141 Cr | ₹149 Cr |
| ₹46 Cr | ₹46 Cr | ₹38 Cr | ₹29 Cr | ₹21 Cr | ₹19 Cr | ₹30 Cr | ₹24 Cr |
| ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr |
| ₹20 Cr | -₹9 Cr | ₹42 Cr | ₹8 Cr | -₹4 L | ₹55 L | ₹12 Cr | ₹10 Cr |
| ₹22 Cr | -₹10 Cr | ₹43 Cr | ₹8 Cr | ₹29 L | ₹75 L | ₹10 Cr | ₹10 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| — | — | — | — | — | — |
| ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹11 Cr | ₹10 Cr | ₹2 Cr |
| ₹45 Cr | ₹37 Cr | ₹67 Cr | ₹89 Cr | ₹26 Cr | ₹0 |
| ₹962 Cr | ₹516 Cr | ₹457 Cr | ₹87 Cr | ₹80 Cr | ₹10 Cr |
| ₹962 Cr | ₹516 Cr | ₹457 Cr | ₹87 Cr | ₹80 Cr | ₹10 Cr |
| ₹1023 Cr | ₹568 Cr | ₹539 Cr | ₹187 Cr | ₹116 Cr | ₹13 Cr |
| ₹0 | ₹1 Cr | ₹4 Cr | ₹43 Cr | ₹10 Cr | ₹0 |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹15 Cr | ₹15 Cr |
| ₹1 Cr | ₹7 Cr | ₹9 Cr | ₹6 Cr | ₹0 | ₹0 |
| ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹6 L |
| ₹13 Cr | ₹8 Cr | ₹7 Cr | ₹4 Cr | ₹13 Cr | ₹2 Cr |
| ₹18 Cr | ₹19 Cr | ₹22 Cr | ₹56 Cr | ₹40 Cr | ₹18 Cr |
| — | — | — | — | — | — |
| ₹74 Cr | ₹51 Cr | ₹73 Cr | ₹59 Cr | ₹66 Cr | ₹33 Cr |
| ₹131 Cr | ₹99 Cr | ₹159 Cr | ₹58 Cr | ₹91 Cr | ₹69 Cr |
| ₹45 Cr | ₹99 Cr | ₹73 Cr | ₹104 Cr | ₹29 Cr | ₹5 Cr |
| ₹8 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr |
| ₹257 Cr | ₹251 Cr | ₹309 Cr | ₹224 Cr | ₹191 Cr | ₹110 Cr |
| ₹1299 Cr | ₹838 Cr | ₹870 Cr | ₹466 Cr | ₹347 Cr | ₹140 Cr |
| ₹39 L | ₹39 L | ₹39 L | ₹47 L | ₹39 L | ₹0 |
| ₹45 Cr | ₹100 Cr | ₹77 Cr | ₹147 Cr | ₹79 Cr | ₹20 Cr |
| — | — | — | — | — | — |
| ₹748 Cr | ₹504 Cr | ₹439 Cr | ₹308 Cr | ₹259 Cr | ₹42 Cr |
| ₹288 Cr | ₹203 Cr | ₹138 Cr | ₹84 Cr | ₹44 Cr | ₹15 Cr |
| ₹460 Cr | ₹301 Cr | ₹301 Cr | ₹224 Cr | ₹215 Cr | ₹27 Cr |
| ₹12 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹12 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹18 Cr | ₹20 Cr | ₹7 Cr | ₹75 Cr | ₹7 Cr | ₹13 Cr |
| ₹88 Cr | ₹99 Cr | ₹94 Cr | ₹13 Cr | ₹16 Cr | ₹48 L |
| ₹578 Cr | ₹420 Cr | ₹405 Cr | ₹317 Cr | ₹239 Cr | ₹41 Cr |
| — | — | — | — | — | — |
| ₹125 Cr | ₹0 | ₹70 Cr | ₹0 | ₹0 | ₹0 |
| ₹181 Cr | ₹161 Cr | ₹146 Cr | ₹80 Cr | ₹57 Cr | ₹55 Cr |
| ₹359 Cr | ₹214 Cr | ₹181 Cr | ₹46 Cr | ₹29 Cr | ₹39 Cr |
| ₹43 Cr | ₹23 Cr | ₹24 Cr | ₹20 Cr | ₹7 Cr | ₹4 Cr |
| ₹14 Cr | ₹20 Cr | ₹45 Cr | ₹3 Cr | ₹15 Cr | ₹2 Cr |
| ₹721 Cr | ₹418 Cr | ₹465 Cr | ₹150 Cr | ₹108 Cr | ₹99 Cr |
| ₹464 Cr | ₹168 Cr | ₹156 Cr | -₹74 Cr | -₹83 Cr | -₹11 Cr |
| ₹1299 Cr | ₹838 Cr | ₹870 Cr | ₹466 Cr | ₹347 Cr | ₹140 Cr |
| ₹123 | ₹72 | ₹64 | ₹18 | ₹18 | ₹54 |
| ₹123 | ₹72 | ₹64 | ₹18 | ₹18 | ₹3 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| ₹51 Cr | ₹10 Cr | -₹75 Cr | -₹106 Cr | -₹87 Cr | -₹23 Cr |
| ₹61 Cr | ₹74 Cr | ₹88 Cr | ₹114 Cr | ₹76 Cr | ₹21 Cr |
| ₹44 Cr | -₹126 Cr | ₹84 Cr | -₹29 Cr | ₹21 Cr | -₹7 Cr |
| ₹156 Cr | -₹42 Cr | ₹96 Cr | -₹22 Cr | ₹10 Cr | -₹8 Cr |
| ₹150 Cr | -₹46 Cr | ₹97 Cr | -₹20 Cr | ₹7 Cr | ₹1 Cr |
| -₹614 Cr | ₹64 Cr | -₹185 Cr | -₹94 Cr | -₹114 Cr | -₹14 Cr |
| ₹271 Cr | ₹4 Cr | ₹218 Cr | ₹137 Cr | ₹96 Cr | ₹28 Cr |
| -₹194 Cr | ₹21 Cr | ₹130 Cr | ₹23 Cr | -₹10 Cr | ₹15 Cr |
| ₹204 Cr | ₹181 Cr | ₹46 Cr | ₹29 Cr | ₹39 Cr | ₹24 Cr |
| ₹24 Cr | ₹3 Cr | ₹4 Cr | -₹6 Cr | ₹89 L | ₹1 L |
| ₹35 Cr | ₹204 Cr | ₹181 Cr | ₹46 Cr | ₹29 Cr | ₹39 Cr |
Fundamental Ratios
Consolidated
Standalone

No results found
Capillary Technologies India Share Price
515.05+0.00 (+2.38%)
-15.08% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 2 out of 9 oscillators
RSI
48.66Neutral
STOCH %K
69.01Neutral
MACD Level(12,26)
-7.76Sell
Ultimate Oscillator
52.49Buy
Aroon Oscillator
36.00Sell
BOP
0.44Buy
CCI
-13.19Neutral
Williams %R
-30.99Neutral
Momentum
12.75Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 6 out of 9 moving averages
EMA 9
508.32Buy
SMA 9
507.51Buy
EMA 21
515.49Sell
SMA 21
517.52Sell
EMA 50
521.27Sell
SMA 50
526.81Sell
EMA 200
544.77Sell
SMA 200
523.10Sell
WMA 20
508.65Buy
Pivot
Pivot
Classic
Resistance 5
580.65
Resistance 4
560.30
Resistance 3
539.95
Resistance 2
519.60
Resistance 1
511.35
Pivot
499.25
Support 1
491.00
Support 2
478.90
Support 3
458.55
Support 4
438.20
Support 5
417.85
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Capillary Technologies India Share Price
515.05+0.00 (+2.38%)
-15.08% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Nov 2025 |
|---|---|---|---|---|
| 47.23% | 51.45% | 52.23% | 52.28% | 52.05% |
| 2.56% | 3.34% | 3.43% | 3.93% | 22.30% |
| 5.68% | 4.56% | 4.58% | 4.97% | 6.57% |
| 16.19% | 14.82% | 14.02% | 12.78% | 6.75% |
| 28.34% | 25.83% | 25.74% | 26.04% | 12.33% |
Bulk & block deals
Name
Irage Broking Services Llp
Swetaben Hardik Shah
Irage Broking Services Llp
Setu Securities Pvt Ltd
F3 Advisors Private Limited
F3 Advisors Private Limited
Swetaben Hardik Shah
Capillary Technologies International Pte Ltd
Setu Securities Pvt Ltd
Irage Broking Services Llp
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 10 Aug 2026 | Purchase | 41.52 Cr | ₹523.83 | 7.93 L | Bulk | 0.996011 | BSE |
| 10 Aug 2026 | Purchase | 23.95 Cr | ₹520.11 | 4.60 L | Bulk | 0.578549 | BSE |
| 10 Aug 2026 | Purchase | 2.05 Cr | ₹526.75 | 38.99 K | Bulk | 0.048996 | NSE |
| 10 Aug 2026 | Sell | 6.15 Cr | ₹524.13 | 1.17 L | Bulk | 0.147541 | BSE |
| 10 Aug 2026 | Sell | 4.31 Cr | ₹524.99 | 82 K | Bulk | 0.103036 | BSE |
| 10 Aug 2026 | Purchase | 23.38 Cr | ₹520.14 | 4.50 L | Bulk | 0.564798 | BSE |
| 10 Aug 2026 | Sell | 3.16 Cr | ₹523.27 | 60.46 K | Bulk | 0.075966 | BSE |
| 10 Aug 2026 | Sell | 171.49 Cr | ₹520.86 | 32.92 L | Bulk | 4.136803 | BSE |
| 10 Aug 2026 | Purchase | 25.87 Cr | ₹520.07 | 4.97 L | Bulk | 0.624996 | BSE |
| 10 Aug 2026 | Sell | 1.76 Cr | ₹527.26 | 33.42 K | Bulk | 0.041991 | BSE |
Insider trading & SAST
Client name
Capillary Technologies International Pte Ltd
Mirae Asset Mutual Fund
Capillary Technologies International Pte.ltd
Mirae Asset Mutual Fund
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24 Aug 2026 | Promoter | Disposal | 4.14 | 44.78 | 0 | — | 32.92 L | 10 Aug 2026 | Market | 3,55,88,819 | SAST | 29(2) | — |
| 16 Jul 2026 | Other | Disposal | 0.5 | 3.47 | 0 | — | 4 L | 19 Jun 2026 | Market | 27,55,770 | SAST | 29(2) | — |
| 02 Jul 2026 | Promoter | Disposal | 0.737393 | 48.92 | 29.16 Cr | ₹497.51 | 5.86 L | 12 Jun 2026 | Block Deal | 3,88,81,247 | Insider Trading | — | Equity |
| 03 Dec 2025 | Other | Acquisition | 0.94 | 5.77 | 0 | — | 7.46 L | 24 Nov 2025 | Market | 45,77,246 | SAST | 29(1) | — |
Capillary Technologies India Share Price
515.05+0.00 (+2.38%)
-15.08% past 1 Year
Capillary Technologies India along with its subsidiaries is primarily engaged in the business of providing cloud based intelligent customer engagement software solutions. Under the company’s operating model, enterprise customers are
Corporate Actions
Date
Type
Details
Company details
Capillary Technologies India Share Price
515.05+0.00 (+2.38%)
-15.08% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Capillary Technologies India Share Price
515.05+0.00 (+2.38%)
-15.08% past 1 Year
News
1 of 20
Stock NewsCAPILLARY16 Nov 2026
The program has already been launched with 50 dealers, marking the first phase of a broader rollout across Hero Cycles’ dealer ecosystem
Capillary Technologies India informs about press release
Stock NewsCAPILLARY16 Nov 2026
NULL
Hero Cycles Selects Capillary Tech For Dealer Loyalty Program Expansion
Stock NewsCAPILLARY16 Nov 2026
Hero Cycles has selected Capillary Technologies to enhance loyalty programs for more than 3,000 dealers. The engagement is expected to support dealer engagement, customer relationship management and loyalty-led business development through Capillary Technologies’ software solutions. The announcement strengthens Capillary Technologies’ presence in the automotive and mobility ecosystem and could support future enterprise revenue opportunities, although financial terms, contract value, implementation timelines and direct earnings impact were not disclosed.
The development is a routine corporate business win and does not involve a merger, acquisition, stake sale, dividend, buyback, capital expenditure commitment, management change or regulatory order. No stock price reaction was provided in the available information. Capillary Technologies India Limited is listed on NSE under CAPILLARY and has ISIN INE0ILV01024.
Capillary Technologies Reports Strong Year On Year EBITDA Growth In Q2
ResultCAPILLARY2 Nov 2026
Capillary Technologies reported Q2 EBITDA of Rs 39.50 crores, compared with Rs 18.60 crores in the corresponding quarter of the previous year, representing year on year growth of approximately 112.4%. EBITDA margin improved to 14.55% from 10.40%, an expansion of 4.15 percentage points. Revenue and PAT figures, quarter on quarter comparisons, and analyst consensus estimates were not provided. The reported improvement in operating profitability indicates stronger earnings performance during the quarter. No management guidance or market reaction was available in the provided information.
Capillary Technologies Reports Strong Q2 Revenue Growth Year on Year
ResultCAPILLARY2 Nov 2026
Capillary Technologies India Limited reported Q2 revenue of Rs 270.00 crores, compared with Rs 179.00 crores in the corresponding quarter last year, representing approximately 50.8 percent year-on-year growth. EBITDA, PAT, operating margin, net margin, sequential revenue change, management commentary, consensus estimates, and market reaction were not provided and are therefore not included.
Capillary Reports Sharp Year On Year Increase In Second Quarter Net Profit
ResultCAPILLARY2 Nov 2026
Capillary Technologies India reported consolidated second-quarter net profit of Rs 22 crores, compared with Rs 30 lakhs in the corresponding quarter a year earlier. This represents a substantial year-on-year improvement in profitability. The available update does not provide revenue, EBITDA, operating margin, net margin, quarter-on-quarter comparison, consensus estimates, or management commentary. Accordingly, no additional financial metrics or guidance are included. The result indicates a sharp expansion in consolidated earnings on a year-on-year basis, although the underlying drivers of the improvement cannot be determined from the available information.
Capillary Tech. Ind reports Profit after tax of 29.43 Crores, in the September 2026 quarter
ResultCAPILLARY2 Nov 2026
NULL
KPMG Confirms External Impersonation In Capillary Technologies Cyber Fraud
Stock NewsCAPILLARY31 Oct 2026
Capillary Technologies India received KPMG’s forensic audit report concerning suspected fraudulent and unauthorised banking transactions at its Czech step-down subsidiary, Session M Czech Republic s.r.o. The report found that the evidence was most consistent with payment-diversion fraud involving impersonation of company executives and legal professionals, social engineering, a lookalike web domain and off-channel communications.
Four disputed overseas payments made between June 26 and July 2 totalled EUR 3,041,169.90. KPMG found no evidence in the reviewed records of malware, compromised mailboxes, traditional email spoofing, technical system issues or employee involvement. However, the report could not independently verify certain approval processes because bank-portal logs and other records were unavailable, and it could neither confirm nor rule out the use of deepfake audio or video.
The findings indicate an external fraud rather than an identified internal control breach or employee-led diversion. The financial impact includes the disputed payment amount, while recovery prospects and any insurance proceeds remain dependent on further investigation and legal or banking actions. The development is company-specific and likely to have a limited immediate impact on broader market indices.
Capillary Technologies India To Meet Analysts And Investors On October 1st
Stock NewsCAPILLARY28 Sept 2026
Capillary Technologies India will hold a meeting with analysts and investors on October 1st. The announcement is an investor engagement event and does not disclose any specific corporate action, financial guidance, transaction value, operational target, or management change. No additional details regarding the agenda or expected disclosures are available.
Capillary block trade valued at Rs 174.62 crore on BSE
Block DealCAPILLARY10 Aug 2026
Capillary saw a BSE block trade valued at Rs 174.62 crore for about 33,44,202 shares at Rs 522.15 apiece.
The available information does not disclose the buyer or seller, and it does not provide a comparison with the prevailing market price or any post-trade share price reaction. Based on the reported trade size and the fact that it is a block deal in a single equity name, the development is primarily a liquidity and ownership-transfer event rather than an operating update.
No additional corporate or regulatory detail is provided in the context, so only the executed transaction value, share count, and price can be stated with confidence.
Capillary Tech Q1 FY27 EBITDA rises QoQ, margin moderates sequentially
ResultCAPILLARY4 Aug 2026
Capillary Tech has reported a sequential improvement in profitability at the operating level for the latest reported quarter. Q1 EBITDA came in at Rs 46.00 crores, compared with Rs 38.10 crores in the previous quarter on a QoQ basis, indicating a healthy increase in operating earnings in absolute terms. This rise in EBITDA suggests improved scale or cost efficiencies, even though detailed revenue and PAT figures are not available in the provided context. Without year-on-year data or street expectations, the performance assessment is restricted to the QoQ comparison.
Despite the stronger EBITDA in absolute terms, EBITDA margin has moderated on a sequential basis. The Q1 EBITDA margin stands at 17.9 percent versus 19.9 percent in the preceding quarter QoQ, reflecting some compression in operating profitability as a proportion of revenue. This margin decline may indicate higher operating costs, changes in business mix, or pricing pressures during the quarter, although the exact drivers are not specified in the statement. In the absence of additional financial metrics such as revenue growth, PAT, or cash flow data, as well as management commentary or guidance, the analysis remains focused on these reported operating metrics.
No information is provided about market expectations, consensus estimates, or immediate share price reaction for CAPILLARY on the NSE/BSE, so relative performance versus street forecasts and market response cannot be inferred. Similarly, there is no disclosed YoY comparison, leverage data, or sectoral context linking these results to broader macro or liquidity trends. Overall, the key takeaway from the available numbers is that Capillary Tech has delivered higher EBITDA in Q1 on a QoQ basis, accompanied by a decline in EBITDA margin, pointing to mixed operating dynamics within the quarter.
Capillary Tech Q1 revenue jumps sequentially to Rs 256 crores
ResultCAPILLARY4 Aug 2026
Capillary Tech has reported Q1 revenue of Rs 256 crores, marking a strong sequential improvement from Rs 190 crores in the previous quarter. This represents a robust quarter-on-quarter increase in topline, indicating accelerating business momentum and improved client activity on its platforms. The substantial revenue gain suggests better demand traction across its key offerings and potentially higher contribution from existing and new customers compared with the immediately preceding quarter.
While detailed profitability metrics such as EBITDA, PAT, and margin trends have not been disclosed in the provided context, the revenue performance alone points to operational scaling and better utilisation of the company’s technology and service capabilities. In the absence of street consensus data, it cannot be conclusively stated whether the reported numbers beat or missed market expectations, but the absolute growth in revenue is clearly positive from a fundamental standpoint. No specific guidance or management commentary has been referenced, and there is no verified information here on operating or net margins, cost dynamics, or segmental revenue mix. Similarly, data on stock price reaction, movement in NSE/BSE trading, or changes in investor positioning are not available in this context, so any assessment of immediate market response must be avoided.
Given the strong quarter-on-quarter revenue expansion and the lack of any negative accompanying datapoints in the available information, the result appears supportive for earnings sentiment around Capillary Tech. However, a fuller interpretation of the sustainability of this growth would require additional disclosures on profitability, cash flows, and order pipeline, as well as comparison against prior year performance and consensus estimates. For now, the key takeaway is that Capillary Tech has delivered a significantly higher revenue base in Q1 versus the prior quarter, reinforcing the growth narrative around its operations.
Capillary Tech Q1 consolidated PBT rises sequentially on improved profitability
ResultCAPILLARY4 Aug 2026
Capillary Technologies reported a sequential improvement in profitability for the latest quarter, with consolidated profit before tax (PBT) coming in at Rs 25.00 crores for Q1. This compares with consolidated PBT of Rs 17.50 crores in the immediately preceding quarter on a quarter-on-quarter basis, indicating a meaningful uptick in pre-tax earnings. The increase in PBT suggests better operating performance or efficiency gains at the company level, even though detailed revenue, EBITDA, PAT and margin data are not available in the provided context. In the absence of explicit figures for revenue growth, operating profit, or net profit, as well as year-on-year comparisons, the focus remains on the clear sequential improvement in consolidated PBT as the key driver of the earnings narrative.
No information has been provided on operating or net margins, street expectations, or consensus estimates, so it is not possible to assess whether the reported PBT outcome was above, in line with, or below market forecasts. Similarly, there is no visibility on management commentary, forward-looking guidance, or any specific drivers such as cost optimisation, product mix changes, or geographic expansion that might have contributed to the higher PBT. Data on the share price reaction, index impact, or changes in trading volumes on NSE/BSE are also unavailable, preventing an assessment of immediate market response to these results. Given these limitations, the earnings update for Capillary Technologies is best characterised as a concise indication of stronger quarter-on-quarter profitability at the consolidated level, anchored solely on the reported step-up in PBT from Rs 17.50 crores to Rs 25.00 crores.
Capillary Technologies orders KPMG forensic audit into suspected banking transaction fraud
Stock NewsCAPILLARY31 Jul 2026
Capillary Technologies India has initiated a forensic audit to investigate suspected fraudulent banking transactions linked to the company. The move indicates that the management has identified irregularities or red flags in certain bank-related dealings and is seeking an independent, detailed examination to establish the extent, parties involved, and potential financial implications. The audit is being conducted by KPMG Assurance and Consulting Services LLP, suggesting that the company has engaged a large, established professional services firm with expertise in forensic accounting, risk assessment, and internal control evaluation. While specific quantum of the suspected fraud, affected accounts, counterparties, and timeline of transactions have not been disclosed in the available context, the decision to launch a forensic audit typically points to concerns around possible misappropriation of funds, falsification of records, or unauthorized transactions routed through banking channels. This development is important for stakeholders as it may lead to identification of control weaknesses, restatement of certain financial information, or changes in processes related to treasury operations and banking relationships. The outcome of the audit could also prompt corrective governance measures such as strengthening internal controls, revising authorization matrices, or enhancing oversight by the board and audit committee. At this stage, there is no public detail on any parallel regulatory proceedings, law enforcement involvement, or impact on ongoing business operations, customer relationships, or liquidity. However, markets generally monitor such forensic reviews closely, as findings may influence investor perception of corporate governance standards and transparency. Until more verified information is released by formal filings or detailed disclosures, the key takeaway is that Capillary Technologies India is proactively subjecting suspected banking transaction irregularities to an independent forensic examination by KPMG.
Capillary Technologies to host Q1 FY27 earnings call on August 4
Stock NewsCAPILLARY28 Jul 2026
Capillary Technologies India has announced that it will hold its Q1 earnings call on August 4 at 4 pm. The scheduled interaction is expected to focus on the company’s financial and operational performance for the first quarter of the current financial year, including revenue trends, profitability metrics, client additions, and key business developments. Management may also provide guidance on upcoming quarters, strategic initiatives, and market conditions in its core technology and customer engagement segments. The timing of the call positions it as an important event for investors and analysts tracking the company’s growth trajectory, competitive positioning, and execution against its stated business plans.
While no specific financial figures, margin details, or segment-wise performance data have been disclosed in the context provided, earnings calls typically offer deeper insight into demand trends, deal pipeline visibility, cost structures, and any ongoing investments in product development or geographic expansion. Participants may look for commentary on the sustainability of growth, any potential impact on leverage or cash flows, and the company’s approach to capital allocation, though such details will only be known once the call takes place. In the absence of concrete numbers or management commentary at this stage, the announcement primarily serves as a formal notification for stakeholders to track and attend the scheduled Q1 earnings discussion.
Capillary Techno Ind - Quaterly Results
ResultCAPILLARY6 May 2026
NULL
Capillary Tech Reports Q4 EBIT Growth to Rs 31.40 Crores, Margin Expands to 16.41% QoQ
ResultCAPILLARY6 May 2026
Capillary Technologies has announced its Q4 financial results, recording EBIT of Rs 31.40 crores, marking an improvement from Rs 25.00 crores in the previous quarter. This represents a sequential growth in profitability for the period.
The EBIT margin expanded to 16.41% from 13.6% QoQ, indicating enhanced operational efficiency. The results highlight positive momentum in the company's core business performance on a quarter-over-quarter basis. No YoY comparisons or additional metrics such as revenue, PAT, or guidance were disclosed in the update.
These figures reflect Capillary Tech's ability to scale profitability amid its operations in the technology sector focused on customer engagement solutions.
Capillary Tech Q4 Consolidated Net Profit Rises to Rs 43.40 Crores from Rs 8.00 Crores QoQ
ResultCAPILLARY6 May 2026
Capillary Technologies has reported its consolidated net profit for the fourth quarter at Rs 43.40 crores, marking a substantial increase from Rs 8.00 crores in the previous quarter (QoQ). This performance highlights strong sequential growth in profitability for the period.
The results reflect Capillary Tech's robust operational execution in its core business segments. No details on revenue, EBITDA, or year-over-year comparisons were provided in the announcement. Margin trends and comparisons to street expectations remain unavailable in the current disclosure.
Capillary Technologies (symbol: CAPILLARY), a provider of loyalty management and customer engagement platforms, continues to demonstrate resilience in the technology services sector amid evolving market dynamics.
Capillary Techno Ind reports Profit after tax of 9.89 Crores, in the March 2026 quarter
ResultCAPILLARY6 May 2026
NULL
Capillary Technologies India informs about allotment of equity shares
Stock NewsCAPILLARY17 Apr 2026
NULL

